Who should take GLP-1s?
GLP-1s were built for type 2 diabetes, yet since their discovery as a tool against obesity their popularity has exploded, with nearly one in eight American adults using them to slim down as of last year. Obesity specialist Caroline Apovian argues the field is not asking clearly enough who the drugs are for, and that the highest-risk patients should come first even as the medicines are marketed to the general public. Her warning to casual users is blunt: take a GLP-1 to drop 10 pounds without having the disease of obesity and you may be setting yourself up to stop the medication, gain even more weight back, and end up with a problem you did not start with. Other experts in the discussion, an evolutionary biologist and an obesity physician scientist, weigh what has been overlooked in the rush to embrace these drugs.
For you: If you do not have obesity, this is a reason to think twice before using a GLP-1 for a small amount of weight, since specialists warn rebound gain after stopping is a real risk.
What it shows: Reported by Harvard Gazette and not verified by us: we could not trace this story to a published paper, so treat it as news rather than evidence we have checked.